Bel Ombre in Mauritius is Launched as benchmark for sustainable tourism Breaking Travel News
Emirates reaffirms partnership with Mauritius | News Breaking Travel News
(CNN) — The US Centers for Disease Control and Prevention added just one new destination, the Indian Ocean island nation of Mauritius, to its highest-risk category for travel on Monday.
The weekly travel risk-level update brought good news for islands clustered in and around the Caribbean Sea with nine destinations — including the Bahamas, Jamaica and the Dominican Republic — dropping down one rung from Level 4.
The CDC places a destination at “Level 4: Covid-19 Very High” risk when more than 500 cases per 100,000 residents are registered in the past 28 days.
To recap, just one destination was added to Level 4 on March 14:
CDC: Avoid Level 4 destinations
There are about 125 destinations currently at Level 4. While the number of places in the “very high” risk category has dipped since topping around 140 in February, there are still more places in the Level 4 category than in all the other categories combined.
The CDC advises avoiding travel to Level 4 countries. CDC thresholds for travel health notices are based primarily on the number of Covid-19 cases in a destination.
A view of Bonis Windmill and the Old Port of Mykonos, one of the most popular islands in Greece.
Byron Smith/Getty Images
Tourist favorites stalled on Level 4 include Aruba, Brazil, Canada, Egypt, France, Greece, Peru and Spain. The United Kingdom has been there since July 2021.
Changes at Level 3
Turks and Caicos is renowned for its beaches, including Mudjin Harbour. The island chain in the Atlantic Ocean is now at the CDC’s Level 3.
The Level 3 “high” risk category — which applies to destinations that have had between 100 and 500 cases per 100,000 residents in the past 28 days — saw nine additions on Monday — all islands clustered in the Caribbean and Atlantic. They were:
• British Virgin Islands
• Dominican Republic
• Saint Kitts and Nevis
• Saint Vincent and the Grenadines
• Sint Maarten
• Turks and Caicos Islands
They were all previously listed at Level 4.
Levels 2, 1 and unknown
Destinations carrying the “Level 2: Covid-19 Moderate” designation have seen 50 to 99 Covid-19 cases per 100,000 residents in the past 28 days. The four new entries to Level 2 on March 14 are:
• Cruise ship travel
They were all previously listed at Level 3. Cruise travel previously dropped from Level 4 to Level 3 in mid-February and is now considered “moderate” risk at Level 2.
To be in “Level 1: Covid-19 Low,” a destination must have fewer than 50 new cases per 100,000 residents over the past 28 days. Eleven places moved to Level 1 on Monday:
• Burkina Faso
• Equatorial Guinea
• São Tomé and Príncipe
The only destinations now listed at Level 1 outside of Africa are China, Taiwan and the small Caribbean island of Saba.
Finally, there are destinations for which the CDC has an “unknown” risk because of a lack of information. Usually, but not always, these are small, remote places or places with ongoing warfare or unrest. The CDC made no new additions to the category on Monday.
Tanzania, Cambodia and Macau are among the more-visited locations currently listed in the unknown category. The CDC advises against travel to these places precisely because the risks are unknown.
A medical expert weighs in on risk levels
Transmission rates are “one guidepost” for travelers’ personal risk calculations, according to CNN Medical Analyst Dr. Leana Wen.
“We are entering a phase in the pandemic where people need to make their own decisions based on their medical circumstances as well as their risk tolerance when it comes to contracting Covid-19,” Wen said in mid-February.
“You should interpret Level 4 to mean this is a place with a lot of community transmission of Covid-19. So if you go, there is a higher chance that you could contract the coronavirus,” said Wen, who is an emergency physician and professor of health policy and management at the George Washington University Milken Institute School of Public Health.
Some people will decide the risk is too high for them, Wen said. “Other people will say, ‘Because I am vaccinated and boosted, I am willing to take on that risk.’
“So this really needs to be a personal decision that people weigh understanding that right now the CDC is classifying the different levels based on community transmission rates, and basically only that,” Wen said. “They’re not taking into account individual circumstances.”
More considerations for travel
There are other factors to weigh in addition to transmission rates, according to Wen.
“The transmission rates are one guidepost,” Wen said. “Another is what precautions are required and followed in the place that you’re going and then the third is what are you planning to do once you’re there.
“Are you planning to visit a lot of attractions and go to indoor bars? That’s very different from you’re going somewhere where you’re planning to lie on the beach all day and not interact with anyone else. That’s very different. Those are very different levels of risk.”
Vaccination is the most significant safety factor for travel since unvaccinated travelers are more likely to become ill and transmit Covid-19 to others, Wen said.
“People who are unvaccinated remain at high risk and really should not be traveling at this point,” she said.
People should be wearing a high-quality mask — N95, KN95 or KF94 — anytime they’re in crowded indoor settings with people of unknown vaccination status, she said.
And it’s also important to consider what you would do if you end up testing positive away from home. Where will you stay and how easy will it be to get a test to return home?
Top image: Flic en Flac beach on the western coast of Mauritius on November 3, 2021. (Photo by Laura Morosoli / AFP via Getty Images)
Mauritius loosens Covid-19 testing requirements | News Breaking Travel News
Many of the credit card offers that appear on the website are from credit card companies from which ThePointsGuy.com receives compensation. This compensation may impact how and where products appear on this site (including, for example, the order in which they appear). This site does not include all credit card companies or all available credit card offers. Please view our advertising policy page for more information.
Editorial Note: Opinions expressed here are the author’s alone, not those of any bank, credit card issuer, airlines or hotel chain, and have not been reviewed, approved or otherwise endorsed by any of these entities.
Mauritius has launched its Covid-19 vaccination programme giving priority to frontline workers including health care professionals, employees of the tourism industry.
Senior citizens and those with underlying medical conditions are also among those to get the jab.
Some 50,000 front liners are being considered for the vaccination campaign, with 50 per cent of them being in the tourism sector.
The government said objective remains the restart of the tourism sector in the safest conditions possible.
Strict quarantine measures and thorough testing protocols have been in place since the outbreak with the hotel industry playing a key role in offering accommodation for confinements.
There has been little to no disruption of social life in Mauritius since June with practically no known cases of community transmission.
As a result, the country has seen an increase in demand from visitors looking to relocate to a Covid-safe environment for work, leisure or retirement.
The Premium Visa has been introduced for this purpose and allows for extended visits of 12 months with an option for further extensions.
Entry restrictions and quarantine requirements are expected to be eased progressively based on the evolution of the pandemic and upon visitors having achieved immunity.
The ultimate objective of the vaccination campaign is to inoculate 60 per cent of the population of 1.3 million to achieve herd immunity.
The first batch of the Oxford-AstraZeneca vaccine, produced by the Serum Institute of India, arrived from Mumbai on Friday as a donation from the government of India.
Doses required to complete the vaccination campaign are expected from Oxford-AstraZeneca and Pfizer with an initial consignment approved through the COVAX facility.